Experience

Mark Ballantyne

    • LogicBio Therapeutics – $80.5 Million IPO 


    • Verrica Pharmaceuticals – $86 Million IPO 


    • Translate Bio – $122 Million IPO 


    • Aclaris Therapeutics IPO 


    • Axovant Completes $362 Million IPO 


    • KemPharm Completes its IPO 


    • Vascular Biogenics Prices IPO 


    • T2 Biosystems IPO 


    • 2U $119 Million Initial Public Offering 


    • Amedica Initial Public Offering 


    • First US IPO of 2014 for GlycoMimetics 


    • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals